Medi Caps: Submission of Unaudited Standalone & Consolidated financial Result for the quarter and half year ended…
Medi Caps (MEDICAPQ) filed a disclosure titled "Submission of Unaudited Standalone & Consolidated financial Result for the quarter and half year ended 30.09.2026". The company is valued at about ₹26.55 crore.
What happened
Medi Caps (MEDICAPQ) filed a disclosure with the exchanges on 4 November 2026 at 04:58 PM titled "Submission of Unaudited Standalone & Consolidated financial Result for the quarter and half year ended 30.09.2026".
Company snapshot
Medi Caps is a micro-cap company, with a market value of about ₹26.55 crore.
The stock last traded at ₹21.29, against a 52-week range of ₹20.33–₹36.8 (42.1% below the high).
Before this filing the shares had moved −14.4% over the month. Average daily turnover over the last 20 sessions was about ₹0.01 crore.
Promoters held 51.44% at the end of Q1 FY27, up 0.08% points from the previous quarter.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | — | -0.4 | -0.32 |
| Q2 FY26 | 1 | 0.3 | 0.23 |
| Q3 FY26 | 1 | 0.3 | 0.23 |
| Q4 FY26 | 1 | -0.3 | -0.25 |
| Q1 FY27 | 0 | -0.6 | -0.47 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.